Establishment of a Brazilian line of human embryonic stem cells in defined medium: Implications for cell therapy in an ethnically diverse population

Cell Transplantation

Volumn 20, Issue 3, 2011, Pages 431-440

  Fraga, Ana M ^a,b   Sukoyan, Marina ^c   Rajan, Prithi ^d   Braga, Daniela Paes de Almeida Ferreira ^e   Iaconelli Jr , Assumpto ^e   Franco Jr , José Gonçalves ^f   Borges Jr , Edson ^e   Pereira, Lygia V ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Centro Regional de Hemoterapia de Ribeirão Preto   (Brazil)

^c ENERGY SYSTEMS INSTITUTE   (Russian Federation)

^d Agni Consulting Services   (United States)

^e Associacao Instituto Sapientiae   (Brazil)

^f Centro de Reproducao Humana Prof Franco Junior   (Brazil)

Author keywords

Brazilian population; Cell banking; Defined medium; Genetic diversity; Human embryonic stem cells

Indexed keywords

ARTICLE; BRAZIL; CELL DIFFERENTIATION; CELL LINE; CELL THERAPY; CULTURE MEDIUM; EMBRYO; EMBRYONIC STEM CELL; ETHNIC DIFFERENCE; GENETIC VARIABILITY; HLA SYSTEM; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL;

BIOLOGICAL MARKERS; BRAZIL; CELL CULTURE TECHNIQUES; CELL LINE; CULTURE MEDIA; EMBRYONIC STEM CELLS; HISTOCOMPATIBILITY; HLA ANTIGENS; HUMANS; KARYOTYPING; TISSUE BANKS;

EID: 79955816862     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368910X522261     Document Type: Article

References (40)

1. Abdeen, H.; McErlean, C.; Moraes, M. E.; Torres, M.; Campiotto, S.; Galvão, S.; Gouvea, C.; Middleton, D. Identification of three novel alleles of HLA-DRB1 and HLA-A in the Brazilian population. Tissue Antigens 69(6):607-610; 2007.
2. Alper, J. Geron gets green light for human trial of ES cell-derived product. Nat. Biotechnol. 27(3):213-214; 2009.
3. Bastos-Rodrigues, L.; Pimenta, J. R.; Pena, S. D. J. The genetic structure of human populations studied through short insertion-deletion polymorphisms. Ann. Hum. Genet. 70:658-665; 2006.
4. Bouzas, L. F.; Salatiel, I.; Salomao, I.; Oliveira, D.; Paraguassu ́-Braga, F.H.; Abdelhay, E. Análise preliminar das frequências de alelos de HLA nas unidades armazenadas no Brasilcord, dos doadores do Redome e dos pacientes inscritos no Rereme como amostra da populac ̧ão brasileira. Rev. Bras. Hematol. Hemoter. 30:34-35; 2008.
5. Bradley, J. A.; Bolton, E. M.; Pedersen, R. A. Stem cell medicine encounters the immune system. Nat. Rev. Immunol. 2:859-871; 2002.
6. Brazilian Institute of Geography and Statistics. www.ibge. gov.br
7. Condic, M. L.; Rao, M. Regulatory issues for personalized pluripotent cells. Stem Cells 26:2753-2758; 2008.
8. Drukker, M.; Benvenisty, N. The immunogenicity of hu- man embryonic stem-derived cells. Trends Biotechnol. 22: 136-141; 2004.
9. Drukker, M.; Katchman, H.; Katz, G.; Even-Tov Fried-man, S.; Shezen, E.; Hornstein, E.; Mandelboim, O.; Reisner, Y.; Benvenisty, N. Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells. Stem Cells 24:221-229; 2006.
10. European Human Embryonic Stem Cell Registry. www. hescreg.eu
11. Fernandes, A. M.; Meletti, T.; Guimarães, R.; Stelling, M. P.; Marinho, P. A. N.; Valladão, A. S.; Rehen, S. K. Worldwide survey of published procedures to culture human embryonic stem cells. Cell Transplant. 19(5):509-523; 2010.
12. Geron. www.geron.com
13. Gosden, C.; Davdson, C.; Robertson, M. Lymphocyte culture. In: Rooney, D. E.; Czepulkowsky, B. H., eds. Human cytogenetics. Oxford, UK: Oxford University Press; 1992: 37-47.
14. Guasch, G.; Fuchs, E. Mice in the world of stem cell biology. Nat. Genet. 37(11):1201-1206; 2005.
15. International Stem Cell Registry. University of Massachusetts Medical School. www.umassmed.edu/Content.aspx?id=47856
16. Itskovitz-Eldor, J.; Schuldiner, M.; Karsenti, D.; Eden, A.; Yanuka, O.; Amit, M.; Soreq, H.; Benvenisty, N. Differ- entiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers. Mol. Med. 6:88-95; 2000.
17. Josephson, R.; Sykes, G.; Liu, Y.; Ording, C.; Xu, W.; Zeng, X.; Shin, S.; Loring, J.; Maitra, A.; Rao, M. S.; Auerbach, J.M. A molecular scheme for improved characterization of human embryonic stem cell lines. BMC Biol. 4:28; 2006.
18. Kelley, J.; Walter, L.; Trowsdale, J. Comparative genomics of major histocompatibility complexes. Immunogenetics 56(10):683-695; 2005.
19. Kobayashi, N.; Yuasa, T.; Okitsu, T. Regenerative medicine for diabetes mellitus. Cell Transplant. 18(5):491-496; 2009.
20. Krepischi-Santos, A. C.; Rajan, D.; Temple, I. K.; Shrubb, V.; Crolla, J. A.; Huang, S.; Beal, S.; Otto, P. A.; Carter, N.P.; Vianna-Morgante, A.M.; Rosenberg, C. Constitutional haploinsufficiency of tumor suppressor genes in mentally retarded patients with microdeletions in 17p13.1. Cytogenet. Genome Res. 125:1-7; 2009.
21. Kumar, N.; Hinduja, I.; Nagvenkar, P.; Pillai, L.; Zaveri, K.; Mukadam, L.; Telang, J.; Desai, S.; Mangoli, V.; Mangoli, R.; Padgaonkar, S.; Kaur, G.; Puri, C.; Bhartiya, D. Derivation and characterization of two genetically unique human embryonic stem cell lines on in-house- derived human feeders. Stem Cells Dev. 18(3):435-445; 2009.
22. Laurent, L. C.; Nievergelt, C. M.; Lynch, C.; Fakunle, E.; Harness, J. V.; Schmidt, U.; Galat, V.; Laslett, A. L.; Otonkoski, T.; Keirstead, H.S.; Schork, A.; Park, H.S.; Loring, J.F. Restricted ethnic diversity in human embryonic stem cell lines. Nat. Methods 7(1):6-7; 2010.
23. Lin, G.; Xie, Y.; Ouyang, Q.; Qian, X.; Xie, P.; Zhou, X.; Xiong, B.; Tan, Y.; Li, W.; Deng, L.; Zhou, J.; Zhou, D.; Du, L.; Cheng, D.; Liao, Y.; Gu, Y.; Zhang, S.; Liu, T.; Sun, Y.; Lu, G. HLA-matching potential of an established human embryonic stem cell bank in China. Cell Stem Cell 5(5):461-465; 2009.
24. Lu, J.; Hou, R.; Booth, C. J.; Yang, S. H.; Snyder, M. Defined culture conditions of human embryonic stem cells. Proc. Natl. Acad. Sci. USA 103(15):5688-5693; 2006.
25. Ludwig, T. E.; Bergendahl, V.; Levenstein, M. E.; Yu, J.; Probasco, M. D.; Thomson, J. A. Feeder-independent culture of human embryonic stem cells. Nat. Methods 3: 637-646; 2006.
26. Ludwig, T. E.; Levenstein, M. E.; Jones, J. M.; Berggren, W. T.; Mitchen, E. R.; Frane, J. L.; Crandall, L. J.; Daigh, C.A.; Conard, K.R.; Piekarczyk, M.S.; Llanas, R.A.; Thomson, J.A. Derivation of human embryonic stem cells in defined conditions. Nat. Biotechnol. 24(2):185-187; 2006.
27. Mosher, J. T.; Pemberton, T. J.; Harter, K.; Wang, C.; Buzbas, E. O.; Dvorak, P.; Simo ́n, C.; Morrison, S. J.; Rosenberg, N.A. Lack of population diversity in commonly used human embryonic stem-cell lines. N. Engl. J. Med. 362(2):183-185; 2010.
28. Nakajima, F.; Tokunaga, K.; Nakatsuji, N. Human leukocyte antigen matching estimations in a hypothetical bank of human embryonic stem cell lines in the Japanese population for use in cell transplantation therapy. Stem Cells 25:983-985; 2007.
29. Pena, S. D. J. Brazilians and the variable mosaic genome paradigm. In: Mayo, O.; Leach, C., eds. Fifty years of human genetics: A festschrift and liber amicorum to celebrate the life and work of George Robert Fraser. Kent Town, SA, Australia: Wakefield Press Pty, Limited; 2007: 98-104.
30. Pena, S. D. J.; Bastos-Rodrigues, L.; Pimenta, J. R.; Byd- lowski, S. P. DNA tests probe the genomic ancestry of Brazilians. Braz. J. Med. Biol. Res. 42:870-876; 2009.
31. Revazonva, E. S.; Turovets, N. A.; Kochetkova, O. D.; Agapova, L. S.; Sebastian, J. L.; Pryzhkova, M. V.; Smolnikova, V. I. U.; Kuzmichev, L. N.; Janus, J. D. HLA homozygous stem cell lines derived from human parthe- nogenetic blastocysts. Cloning Stem Cells 10:11-24; 2008.
32. Swijnenburg, R. J.; Schrepfer, S.; Govaert, J. A.; Cao, F.; Ransohoff, K.; Sheikh, A. Y.; Haddad, M.; Connolly, A.J.; Davis, M.M.; Robbins, R.C.; Wu, J.C. Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts. Proc. Natl. Acad. Sci. USA 105(35):12991-12996; 2008.
33. Taylor, C.; Bolton, E. M.; Pocock, S.; Sharples, L. D.; Pedersen, R. A.; Bradley, J. A. Banking on human embryonic stem cells: Estimating the number of donor cell lines needed for HLA matching. Lancet 366:2019-2025; 2005.
34. The MHC Sequencing Consortium. Complete sequence and genemap of a human major histocompatibility complex. Nature 401(6756):870-871; 1999.
35. Thomson, J.A.; Itskovitz-Eldor, J.; Shapiro, S.S.; Waknitz, M.A.; Swiergiel, J.; Marshall, V.S.; Jones, J.M. Embryonic stem cell lines derived from human blastocysts. Science 282:1145-1147; 1998.
36. Triunfol, M. Human embryonic stem-cell research reapproved in Brazil. Lancet Oncol. 9(7):616; 2008.
37. Unger, C.; Skottman, H.; Blomberg, P.; Dilber, M.S.; Hovatta, O. Good manufacturing practice and clinical- grade human embryonic stem cell lines. Hum. Mol. Genet. 17(R1):48-53; 2008.
38. Yamanaka, S. Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell 1(1):39-49; 2007.
39. Yang, X.; Smith, S. L.; Tian, X. C.; Lewin, H. A.; Renard, J. P.; Wakayama, T. Nuclear reprogramming of cloned embryos and its implications for therapeutic cloning. Nat. Genet. 39(3):295-302; 2007.
40. Yao, S.; Chen, S.; Clark, J.; Hao, E.; Beattie, G. M.; Hayek, A.; Ding, S. Long-term self-renewal and directed differentiation of human embryonic stem cells in chemically defined conditions. Proc. Natl. Acad. Sci. USA 103: 6907-6912; 2006.